About Timothy Cannon, MD
Dr. Cannon is a specialty care physician board certified in medical oncology. He joins Inova Medical Group with over 6 years of clinical experience in oncology. He has a special interest in management of gastrointestinal malignancies.
Dr. Cannon is the clinical director and moderator of the weekly molecular tumor board at Inova, which matches patients with targeted therapies based on molecular diagnostics. He is very interested in national cooperative group clinical trials and is a member of the NRG colorectal and non-colorectal clinical trials committee. He is the site principal investigator for multiple clinical trials in immunotherapy.
Dr. Cannon is chair-elect of the steering committee for the TAPUR trial, which is the largest oncology basket trial in North America. He also served as the chief fellow of hematology/oncology at New York University (NYU). Dr. Cannon was voted fellow of the year at NYU during each of his last two years there. He received a "best doctor" award by Northern Virginia magazine in 2015.
A native of New Jersey, Dr. Cannon is married with 2 sons. His wife, Amy, works for Save the Children. In his spare time, he likes to play sports (particularly soccer, flag football, tennis) and read books. He was a member of two Division I basketball teams (University of Utah as a freshman and then later at Brigham Young University) in the 1990s and continues to be a huge basketball fan.
- Assistant Professor, Department of Medicine, Virginia Commonwealth University
- NYU Chief Fellow of Hematology/Oncology 2010-2011
- NYU Fellow of the Year 2011
- NYU Fellow of the Year 2010
- American Society of Clinical Oncology
- Top Docs, Washingtonian, 2020
Research and Publications
Immunotherapy: Cancer Care Gets Customized. October 11, 2017.
Colon Cancer in Young Adults: Know Your Risk. April 6, 2017.
David Bowie and Liver Cancer: Bringing Awareness to the Disease and Promising New Treatments on the Horizon. January 19, 2016.
Why Us and not the Elephants? November 5, 2015.
Supplements: Proceed with Caution. August 10, 2015.
Pharmacogenomics: Personalized Medicine in Action. August 3, 2015.
Drugs blocking tumor proteins offer hope for cancer outcomes. June 26, 2015.
Mixed Nuts with Mixed Results. June 24, 2015.
Medical EducationRutgers Medical School 2005
Training Specialty: Internal Medicine
6/23/2005 - 6/30/2008
Training Specialty: Hematology/Oncology
7/1/2008 - 7/1/2011